An Economic Analysis of a Randomized, Controlled, Multicenter Study of Clinical Pharmacist Interventions for High-Risk Veterans: The IMPROVE Study
| Autor: | Kelly Guthrie, Robert Dombrowski, Debra J. Barnette, Robert J. Valuck, Lubica Sloboda, Mary G. Amato, Barbara J. Mason, Samuel L. Ellis, Douglas R. Geraets, Charles D. Sintek, Sarah J. Billups, Jannet M. Carmichael, Douglas Covey, Barry L. Carter, Gary J. Okano, Sandra G. Jue, Daniel C. Malone |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
education.field_of_study business.industry Population Psychological intervention Chemist Clinical pharmacy Pharmaceutical care Health care Ambulatory Physical therapy medicine Pharmacology (medical) business education Veterans Affairs health care economics and organizations |
| Zdroj: | Pharmacotherapy. 20:1149-1158 |
| ISSN: | 0277-0008 |
| DOI: | 10.1592/phco.20.15.1149.34590 |
| Popis: | Study Objective. To determine if clinical pharmacists could affect economic resource use and humanistic outcomes in an ambulatory, high-risk population. Design. Prospective, randomized, controlled study. Setting. Nine Veterans Affairs medical centers. Patients. Patients who were at high risk for medication-related problems. Intervention. Patients were randomized to usual medical care with input from a clinical pharmacist (intervention group) or just usual medical care (control group). Measurements and Main Results. Of 1054 patients enrolled, 523 were randomized to the intervention group and 531 to the control group. The number of clinic visits increased in the intervention group (p=0.003), but there was no difference in clinic costs. Mean increases in total health care costs were $1020 for the intervention group and $1313 for the control group (p=0.06). Conclusion. Including the cost of pharmacist interventions, overall health care expenditures were similar for patients randomized to see a clinical pharmacist versus usual medical care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text